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Purpose: To describe vision loss associated with the use or removal of silicone oil retinal 
tamponade.
Methods: Records were reviewed of all patients with a decrease in visual acuity of at least 
3 Snellen lines from best acuity with 5000 centistoke silicone oil in place or after removal of 
silicone oil at a single retina-only practice between 1996 and 2006.
Results: Nine patients (6 men, 3 women) with a mean age of 48 years (range, 16–61) met study inclusion 
criteria. Seven patients lost at least three Snellen lines of vision while the silicone oil was in place. Four 
patients had late modest improvements in acuity when compared to their ﬁ  nal recorded Snellen vision 
before silicone oil removal, however no patients exhibited visual improvement when comparing their 
ﬁ  nal recorded visual acuities after oil removal with best recorded acuities under oil tamponade. Loss 
of the foveal depression was a consistent feature on optical coherence tomography.
Conclusions: Vision loss is a possible complication of silicone oil use and removal. Late 
visual improvement may occur in some patients. Further research is warranted to elucidate the 
mechanism(s) of vision loss associated with the use or removal of silicone oil.
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Introduction
Silicone oil for use during vitreoretinal surgery was ﬁ  rst reported in the United 
States by Paul Cibis in 1962, although almost two decades passed before the agent 
gained general acceptance among American vitreoretinal surgeons (Cibis et al 1962). 
The long-lasting retinal tamponade provided by silicone oil is of particular beneﬁ  t 
when attempting to repair retinal detachments associated with severe proliferative 
vitreoretinopathy, diabetic retinopathy, viral retinitis, and ocular trauma (Gallemore 
and McCuen). Since its introduction, there has been controversy concerning the 
safety of silicone oil for intraocular use (Cibis et al 1962; Okun 1965; Post 1965; 
Fuller 1986).
Removal of silicone oil is typically advocated for a number of reasons. Prolonged 
silicone oil tamponade has been demonstrated to induce anterior segment complications, 
including cataract, glaucoma, and keratopathy (Chan and Okun 1986). Data obtained 
from enucleated, glaucomatous eyes suggest that silicone oil droplets can become 
impregnated within the neuroretina, pigment epithelium, optic nerve, and trabecular 
meshwork (Honda et al 1986; Shields and Eagle 1989). Finally, removal of silicone 
oil is commonly associated with improved visual acuity because of the mitigation of 
refractive errors.
Unexplained loss of vision in eyes following silicone oil removal has recently been 
described in two reports (Newsom et al 2004; Cazabon et al 2005). Although several possible 
hypotheses were advanced, neither report provides a conclusion as to the pathophysiology 
of the vision loss. The current study examines visual loss both during the time of silicone 
oil tamponade and after oil removal.Clinical Ophthalmology 2008:2(4) 956
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Methods
Medical records were reviewed of all patients with a 
documented loss of visual acuity of at least three Snellen lines 
from best acuity with silicone oil in place or after removal of 
silicone oil at a single retina practice in Dallas and Arlington, 
Texas between 1996 and 2006. Data collected include age, 
gender, involved eye, type of retinal detachment, macular sta-
tus at the time of surgery, type of surgery performed, duration 
(in days) of silicone oil ﬁ  ll, and visual acuity during and after 
silicone oil tamponade. Visual acuity through intraocular oil 
was recorded using a potential acuity meter. Visual acuity after 
oil removal was recorded with a Snellen chart. The results of 
any ancillary testing performed (such as ﬂ  uoroscein angiog-
raphy, optical coherence tomography [OCT], and perimetry) 
were also recorded.
Results
Nine patients (six men, three women) with a mean age 
of 48 years (range, 16 to 61 years) met study inclusion 
criteria. Clinical characteristics of the study population are 
summarized in Table 1. In seven eyes, perﬂ  uorocarbon liquid 
was used during retinal detachment repair to ﬂ  atten the retina. 
All cases were performed with 5000-centistoke silicone oil. 
All eyes underwent 360-degree laser retinopexy, and all eyes 
maintained retinal attachment.
Visual acuity data during and after the period of silicone oil 
tamponade are presented in Table 2. Seven patients lost at least 
three Snellen lines of vision while the silicone oil was in place. 
Four patients had late modest improvements in acuity when 
compared to their ﬁ  nal recorded Snellen vision before silicone 
oil removal, however no patients exhibited visual improvement 
when comparing their ﬁ  nal recorded visual acuities after oil 
removal with best recorded acuities under oil tamponade
The average time of silicone oil ﬁ  ll was 469 days (range, 
80–3104 days; median 119 days). Patient 8 refused to have 
oil removal for eight years due to good vision with the oil in 
place. If the data from patient 8 is excluded as an outlier, a 
more representative mean of 139 days is derived. The median 
best recorded visual acuity by potential acuity meter testing 
with in place was 20/40 at a median of 27 days after oil place-
ment (range, 6–1285 days; mean, 176 days; mean is 37 days if 
patient 8 is excluded). The median visual acuity by potential 
acuity meter at the last visit before removal of silicone oil 
was 20/200 (range, 20/40–20/400). Patients were followed for 
Table 1 Patient and ocular characteristics in study population with visual acuity loss associated with silicone oil use or removal










Timing of cataract 
extraction and IOL
1 61 Multiple 
inferior tears
No Yes Yes After SO removal
2 51 Giant retinal 
tear
No Yes Yes After SO removal
3 58 Inferior 
recurrent 
RD with PVR
No Yes Yes After SO removal






No Yes Yes With SO removal







6 57 Recurrent 
inferior RD
High myopia No No
7 52 Giant retinal 
tear
No Yes Yes After SO removal
8 44 Recurrent 
inferior RD 
with PVR
High myopia Yes No
9 57 Giant retinal 
tear
Yes Yes Yes Extraction with SO 
placement, IOL with 
SO removal
Abbreviations: IOL, Intraocular lens; PVR, proliferative vitreoretinopathy; RD, retinal detachment; SO, silicone oil.Clinical Ophthalmology 2008:2(4) 957
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Table 2   Visual acuity (VA) characteristics during and after silicone oil tamponade
Pt # Best VA with oil 
(PAM)
Days b/t oil 
placement 
and best VA
VA at ﬁ  nal 







Days between oil 




1 20/40 27 20/200 119 CF 249 CF
2 20/50 20 20/70 80 20/60 386 20/60
3 20/40 69 20/200 147 20/200 496 20/400
4 20/50 20 20/200 248 20/100 65 20/100
5 20/40 8 20/300 96 20/120 113 20/120
6 20/60 59 20/400 224 20/400 1218 CF
7 20/40 89 20/40 111 20/100 274 20/100
8 20/30 1285 20/70 3104 20/40 758 20/40
9 20/25 6 20/100 88 20/400 105 20/400
an average of 407 days (range, 65–1218 days) after silicone 
oil removal. The median best recorded visual acuity after oil 
removal was 20/120 (range, 20/40-count ﬁ  ngers) at a mean of 
346 days post removal (range, 54–934 days). Patient 9 had a 
moderate vitreous hemorrhage on the ﬁ  rst postoperative day 
that resolved spontaneously. The median ﬁ  nal recorded visual 
acuity was 20/120 (range, 20/40-count ﬁ  ngers) at a median 
of 274 days (range, 65–1218 days; mean, 407 days).
The results of OCTs performed after silicone oil removal 
are described in Table 4. Patient 8 had a small macular hole 
diagnosed by OCT 72 days after oil removal. The macular 
hole resolved spontaneously 10 months later (conﬁ  rmed by 
OCT), with improvement in visual acuity from 20/100 to 
20/40. Fluorescein angiography was performed on patients 
1, 2, and 3. The angiogram of patient 1 was notable for early 
punctate staining of the macula consistent with ﬁ  ne drusen, 
while patients 2 and 3 demonstrated normal angiography. 
Patient 2 had a normal Goldmann visual ﬁ  eld after oil 
removal and potential acuity meter visual acuity testing 
ranging from 20/100 to 20/300 before cataract extraction.
At no time did any patients exhibit persistent spikes in intra-
ocular pressures, and the investigators never had tangible reason 
to suspect that glaucoma played an important etiologic role in 
any of the aforementioned cases of inexplicable vision loss.
Discussion
Vision loss associated with silicone oil use and removal is 
typically severe and permanent. Vision loss may be masked 
Table 3 Optical coherence tomography ﬁ  ndings after silicone oil removal





1 11 204 Decreased foveal 
depression
2 24 187 Normal OCT
3 48 243 No foveal depression, 
mild CME
4 65 189 Decreased foveal 
depression
5 41 248 Decreased foveal 
depression
6 1218 140 Thin, myopic fundus
7 36 209 Decreased foveal 
depression
8 72 n/a Small macular hole
9 – – No OCT performed
Abbreviations: CME, cystoid macular edema; OCT, optical coherence tomography.Clinical Ophthalmology 2008:2(4) 958
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by the fact that many eyes that receive silicone oil tamponade 
have severe retinal conditions with poor central vision at the 
time of oil placement. Therefore, their physicians assume the 
subsequent limited central vision following oil removal is 
due to pre-existing retinal damage.
In the current study, seven of ten patients had a three 
Snellen line decrease in visual acuity recorded prior to silicone 
oil removal. Herbert and colleagues (2006) noted similar 
ﬁ  ndings in a ﬁ  ve-patient, retrospective study, documenting 
the development of subjective central scotomas in advance of 
oil removal. The oil was in place for an average of 2.7 months 
when the scotomas arose and were associated with decreased 
visual acuity and visual ﬁ  eld defects.
Various theories have been offered to explain the vision 
loss associated with the use, or removal, of silicone oil 
tamponade (Table 5). According to the “vitreous potassium 
sink” theory, the vitreous cavity in a normal eye provides a 
reservoir for the release of potassium ions by Müller cells, 
thereby buffering intraretinal potassium spikes (Winter et al 
2000). This theory was ﬁ  rst presented as an explanation 
for perﬂ  uorocarbon liquid toxicity. It is hypothesized 
that the aqueous volume between the perﬂ  uorocarbon 
and the retina is far too small to serve as a sufﬁ  cient sink 
for the siphoning of potassium ions and that elevated 
retinal potassium concentration could trigger apoptosis 
and macular dysfunction. Cazabon and colleagues (2005) 
proposed the same mechanism as an explanation for 
vision loss associated with silicone oil removal. Figure 1 
demonstrates the existence of a oil-ﬂ  uid interface over the 
foveal depression in a patient without unexpected vision 
loss. The rapid disruption in electrolyte concentration in the 
“potassium sink” may explain the sudden vision loss with 
silicone oil removal. Based on pattern electroretinogram 
and multifocal electrogram testing, Cazabon and colleagues 
(2005) localized the damage to the outer retinal layers of 
the central macula.
Table 4 Potential mechanisms of vision loss associated with the 
use, or removal, of silicone oil
  1.  Vitreous potassium sink
  2.   Fibrogenic growth factors
 3.     Ocular factors (macula-off detachment, myopia, cataract, posterior 
ischemic optic neuropathy)
 4.   Ultraviolet  light
  5.   Reduced fat soluble factors (eg, lutein and zeaxanthin)
Figure 1 Optical coherence tomography image of silicone oil-ﬂ  uid interface over the foveal depression in a patient without associated vision loss.Clinical Ophthalmology 2008:2(4) 959
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The sporadically noted optic neuropathy following 
silicone oil removal has led to the hypothesis that a similar 
“sink” might exist within the optic cup (Satchi et al 2005). 
Based on OCT, an interface similar to that presented in 
Figure 1 exists over the optic cup. Another author, citing 
afferent pupillary defects in a handful of patients, points 
to posterior ischemic optic neuropathy as playing a pos-
sible causative role (Tavallali and Soheilian 2005). This 
was deemed unlikely by Newsom and colleagues given 
their patients’ relative youth, excellent vascular health, 
and, in 6 of 7 patients, preserved visual evoked potentials 
(Newsom et al 2005).
One group of investigators has documented increased 
concentrations of ﬁ  brogenic growth factors (notably basic 
ﬁ  broblast growth factor and interleukin-6) in the retro-oil 
ﬂ  uid (Asaria et al 2004), although this would likely contribute 
more to perisilicone proliferation than unexplained vision 
loss following removal of silicone oil. No such perisilicone 
membranes were documented in these patients.
Silicone oil transmits certain frequencies of ultraviolet 
light more readily than the vitreous gel, and aphakic patients 
might be particularly susceptible to phototoxic damage 
(Azzolini et al 1992). Moreover, silicone oil is believed 
to dissolve fat soluble elements from the retina, most 
notably lutein and zeaxanthin, both of which are widely 
thought to serve photo-protective roles (Refojo et al 1998; 
Herbert et al 2005).
The exact etiology of vision loss in the current study 
group is unknown. Confounding variables such as cataract 
surgery, high myopia, and macular detachment must be 
considered in some patients. Four of eight patients in this 
study had a decrease in the foveal depression on OCT 
(OCTs were not routinely performed, and were only utilized 
when the clinician could not ascertain another viable reason 
for poor visual function in the absence of obvious archi-
tectural abnormalities). The signiﬁ  cance of this ﬁ  nding is 
unclear, but it could suggest a maculopathy with architectural 
foveal changes. Based on the “potassium sink” theory, the 
OCT changes could represent anatomic changes secondary 
to a localized foveal toxicity. Another possibility is simply 
poor ﬁ  xation due to poor vision.
Conclusion
The use of silicone oil is an important management tool for 
many complex retinal conditions. Future studies are warranted 
to evaluate the risk of unanticipated central visual loss.
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